Tag: biosimilar
Current VPAS rate is threat to billions of pound of NHS savings; BGMA proposes reform
The British Generic Manufacturers Association (BGMA) has published a positioning paper which sets out the objectives that need to be delivered through the next...
BGMA calls for VPAS exemption for branded generics and biosimilars
The British Generic Medicines Association (BGMA) has called for exemption from the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS), an agreement between...